Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Current research suggests AOD-9604 does not significantly increase IGF-1 levels like traditional HGH therapy
Safety: Minimizes risk of overdose or underdose
It is better to consult with a physician if you're nursing, pregnant, taking medication, or have a medical condition
This means it can potentially deliver its regenerative signals more directly and effectively
Perform handwashing again and sanitize the injection sites with an alcohol-soaked cotton ball or alcohol pad
Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds
